SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is a top trending stock following its recent earnings report, which showed stronger-than-expected results for the past quarter but included a weaker outlook for the current period due to supply constraints and manufacturing yields. This mixed news has sparked a fervent debate among investors, with many long-term bulls seeing a buying opportunity in the face of temporary challenges, citing the company's AI initiatives, advanced 18A node, and government backing for its foundry efforts. However, others remain cautious, pointing to the soft guidance as evidence of ongoing competitive struggles and concerns about the stock's valuation after its recent strong rally.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune ($ALT) is surging with strong buying interest, as the stock has rallied past key technical resistance levels and achieved a notable close. This momentum is largely driven by investor anticipation following its FDA Breakthrough Therapy Designation for Pemvidutide, fueling widespread speculation of an imminent partnership or acquisition in the active GLP-1/MASH sector. The community is also keenly watching for a potential short squeeze and increased institutional investment now that the stock is trading above $5.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is experiencing a surge in attention due to its extremely low share float and high short interest, fueling intense community speculation for a significant short squeeze. Traders are actively comparing it to other recent microcap parabolic runners, anticipating substantial price increases as the company explores strategic alternatives.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano (MOVE) is experiencing significant speculative interest following its merger announcement with Corvex, an AI cloud computing firm. The catalyst is Corvex's newly secured long-term NVIDIA H200 GPU deployment, fueling community discussion around a potential short squeeze given MOVE's notably low share float. While many anticipate substantial upward movement from the AI and NVIDIA association, others are exercising caution regarding the merger's valuation specifics and potential for volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently announced $150 million direct offering of common shares, sparking widespread discussion. While some investors express concern over dilution and a perceived lack of immediate commercialization news, many see this capital raise as a strategic, bullish move. The community anticipates the funds will accelerate production capabilities and facilitate potential acquisitions like Sivers Semiconductors, positioning POET to meet future demand for its optical interposer technology in the rapidly growing AI data center market, further bolstered by a recent product innovation award.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending sharply higher following its U.S. subsidiary's filing of a consolidated deep-sea mining application with NOAA, significantly expanding its proposed recovery area under new U.S. regulatory frameworks. This development, alongside a congressional hearing featuring TMC's CEO, is driving strong community conviction that the company is poised to lead in securing critical minerals for national security and reducing foreign supply chain dependence.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares are trending as Goldman Sachs recently raised its price target for gold, fueling bullish sentiment. The community is actively debating whether ongoing geopolitical tensions and concerns over fiat currency debasement will drive further record highs or if current overbought conditions signal an impending correction for the popular safe-haven asset.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is drawing significant attention as Elon Musk's comments on solar-powered AI satellites and data centers in space highlight the demand for advanced space infrastructure. The market is actively discussing ASTI's lightweight, flexible thin-film solar technology, seeing it as critical for next-gen constellations and defense initiatives, alongside its strategic partnerships. This has fueled community speculation about a potential short squeeze and substantial upside, given the company's low market capitalization in a rapidly expanding sector.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo Holdings Inc. (BTGO) is trending following its recent IPO as the first digital asset custodian to list in 2026, opening strong but quickly facing significant sell-offs. While some community members are highlighting its substantial revenue and institutional-grade security as a long-term play, others are expressing disappointment over its immediate post-IPO performance, comparing it to other volatile crypto listings and anticipating further declines amidst current crypto market sentiment.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as traders closely watch extreme volatility in natural gas prices, which have surged due to recent cold weather forecasts. The community is actively debating if this natural gas rally is a short-term, possibly manipulated spike, with many accumulating KOLD in anticipation of a significant rebound. Investors are betting on a reversion as ample storage and projected warmer temperatures could lead to a downturn in natural gas prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Mizuho Markets Americas LLC Has $6.45 Million Stake in Haemonetics Corporation $HAE

Mizuho Markets Americas LLC cut its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 43.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC...

Schwartz Investment Counsel Inc. Has $6.69 Million Stock Holdings in Haemonetics Corporation $HAE

Schwartz Investment Counsel Inc. trimmed its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 63.2% in the third quarter, according to the company in its most recent disclosure with the...

Haemonetics (NYSE:HAE) Shares Gap Down - Here's What Happened

Haemonetics (NYSE:HAE) Shares Gap Down - What's Next...

Is it Apt to Retain HAE Stock in Your Portfolio for Now?

Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near-term outlook.

Here's Why Haemonetics (HAE) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Where Haemonetics Stands With Analysts

Barrington Research Forecasts Strong Price Appreciation for Haemonetics (NYSE:HAE) Stock

Barrington Research raised their price target on Haemonetics from $90.00 to $93.00 and gave the company an "outperform" rating in a report on Monday...

Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report?

Haemonetics (HAE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Haemonetics Corp.

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

Current Price	$70.02
Prev Close	$70.11
Open	$69.80
Dividend Yield	0.00%
50-Day Moving Average	$78.94
Beta	0.69
Avg. Volume	726,049.45
PE Ratio	20.45

52-Week High	$87.32
52-Week Low	$47.32
Market Capitalization	$3.28B
EPS (Annual)	$3.31
Price to Book	3.86
Revenue Per Employee	$450,156.80
Enterprise Value/EBITDA	N/A

HAE
Haemonetics Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HAE News

HAEHaemonetics Corp.